Glaxo Smith Kline

Type
Internal restructuring
Country
United Kingdom
Region
North East (England); Northumberland, Durham and Tyne & Wear; Durham
Location of affected unit(s)
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
200 jobs
Number of planned job losses
Job loss
Announcement Date
3 December 2008
Employment effect (start)
3 December 2008
Foreseen end date
3 June 2010

Description

GlaxoSmithKline, a pharmaceutical company, is to cut 200 jobs from its factory in County Durham.The company will reduce the workforce at the plant from 950 to 750 over the next 18 months.The company stated that the reduction was not due to the current financial conditions, but because of the recent expiration of the patent on its anti-nausea drug Zofran, which is made at the factory, and competitors are now making their own version of the drug.

Sources

  • 3 December 2008: The Guardian
  • 3 December 2008: BBC News

Citation

Eurofound (2008), Glaxo Smith Kline, Internal restructuring in United Kingdom, factsheet number 67575, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/67575.